XML 19 R6.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income/(Loss)
Balance, shares (in shares) at Mar. 31, 2018     52,343        
Balance, value at Mar. 31, 2018 $ 752,429 $ 1,176 $ 523 $ 503,955 $ 266,942 $ 1,176 $ (18,991)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Employee stock purchase plan (in shares)     67        
Employee stock purchase plan 3,254   $ 1 3,253      
Exercise of stock options (in shares)     287        
Exercise of stock options 10,191   $ 3 10,188      
Shares repurchased (in shares)     (1,841)        
Shares repurchased (160,000)   $ (18) 1,737 (161,719)    
Issuance of restricted stock, net of cancellations (in shares)     164        
Issuance of restricted stock, net of cancellations 0   $ 1 (1)      
Share-based compensation expense 17,188     17,188      
Net income 55,019       55,019    
Other comprehensive income (loss) (11,389)           (11,389)
Balance, shares (in shares) at Mar. 30, 2019     51,020        
Balance, value at Mar. 30, 2019 667,868   $ 510 536,320 161,418   (30,380)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Employee stock purchase plan (in shares)     45        
Employee stock purchase plan 3,369   $ 1 3,368      
Exercise of stock options (in shares)     232        
Exercise of stock options 8,647   $ 2 8,645      
Shares repurchased (in shares)     (1,483)        
Shares repurchased (175,000)   $ (15) (15,553) (159,432)    
Issuance of restricted stock, net of cancellations (in shares)     509        
Issuance of restricted stock, net of cancellations 0   $ 5 (5)      
Share-based compensation expense 20,454     20,454      
Net income 76,526       76,526    
Other comprehensive income (loss) (14,755)           (14,755)
Balance, shares (in shares) at Mar. 28, 2020     50,323        
Balance, value at Mar. 28, 2020 587,109   $ 503 553,229 78,512   (45,135)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Employee stock purchase plan (in shares)     44        
Employee stock purchase plan 4,013   $ 1 4,012      
Exercise of stock options (in shares)     128        
Exercise of stock options 6,219   $ 1 6,218      
Issuance of restricted stock, net of cancellations (in shares)     374        
Issuance of restricted stock, net of cancellations 0   $ 4 (4)      
Share-based compensation expense 25,516     25,516      
Equity component of convertible notes, net of issuance costs 61,156     61,156      
Purchase of capped call related to convertible notes (47,400)     (47,400)      
Net income 79,469       79,469    
Other comprehensive income (loss) 15,588           15,588
Balance, shares (in shares) at Apr. 03, 2021     50,869        
Balance, value at Apr. 03, 2021 $ 731,670   $ 509 $ 602,727 $ 157,981   $ (29,547)